And then also a colleague that I had, we had, I dont know if you remember the old Hagedorn Research Institute, but Novo actually had kind of like an academic research institute that was affiliated with us
Seattle Wegovy treatment mimics natural GLP-1 hormones, slowing digestion and controlling appetite for steady weight loss
Those who took GLP-1s had a higher survival rate after 10 years and were less likely to have tumors return compared to non-users
and simple carbohydrates like white rice or refined grains are generally better tolerated than heavy, fatty, or highly processed foods
Dose 2.4 mg = 0.96 ml = 96 IU on the insulin syringe
GUO: And so starting around last fall, when the FDA announced that, hooray, the shortage is over, all of these companies were supposed to hand the weight loss drug business back to Eli Lilly and Novo Nordisk